DOI: 10.1055/s-00000133

Gastroenterologie up2date


Van Assche G, Sandborn WJ, Feagan BG et al.
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial.

Gut 2006;
55: 1568-1574

Download Bibliographical Data

Search in: